Prognosis of polymyalgia rheumatica and giant cell arteritis

https://doi.org/10.1016/S0950-3579(05)80068-8Get rights and content

Summary

Polymyalgia rheumatica and giant cell arteritis are amongst the most satisfying conditions for clinicians to diagnose and treat because the unpleasant effects and serious consequences of these conditions can be almost entirely prevented by corticosteroid treatment; the fact that the side-effects of this treatment sometimes seem to be more serious than the complications of the disease is an indication of its effectiveness. Unfortunately, there is no objective way of determining the prognosis in the individual, and decisions concerning duration of treatment remain empirical.

References (67)

  • BagratuniL

    Prognosis in the anarthritic rheumatoid syndrome

    British Medical Journal

    (1963)
  • BarberHS

    Myalgic syndrome with constitutional effects. Polymyalgia Rheumatica

    Annals of the Rheumatic Diseases

    (1957)
  • BehnAR et al.

    Polymyalgia rheumatica and corticosteroids: how much for how long?

    Annals of the Rheumatic Diseases

    (1983)
  • BengtssonBA et al.

    Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica

    Acta Medica Scandinavica

    (1981)
  • BengtssonBA et al.

    Eye complications in giant cell arteritis

    Acta Medica Scandinavica

    (1982)
  • BevanAT et al.

    Clinical and biopsy findings in temporal arteritis

    Annals of the Rheumatic Diseases

    (1968)
  • BirkheadNC et al.

    Treatment of temporal arteritis with adrenal corticosteroids

    Journal of the American Medical Association

    (1957)
  • BownessP et al.

    Prevalence of hypothyroidism in patients with polymyalgia rheumatica and giant cell arteritis

    British Journal of Rheumatology

    (1991)
  • BruceW

    Senile rheumatic gout

    British Medical Journal

    (1888)
  • CaselliRJ

    Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia

    Neurology

    (1990)
  • ChuanTY et al.

    Polymyalgia rheumatica—a 10-year epidemiologic and clinical study

    Annals of Internal Medicine

    (1982)
  • ClearkinLG et al.

    Ocular involvement in giant cell arteritis

    British Journal of Hospital Medicine

    (1990)
  • CookeWT et al.

    Temporal arteritis: a generalised vascular disease

    Quarterly Journal of Medicine

    (1945)
  • CoomesEN et al.

    A prospective study of 102 patients with the polymyalgia rheumatica syndrome

    Rheumatology and Rehabilitation

    (1976)
  • CrosbyRC et al.

    Temporal arteritis

    Archives of Internal Medicine

    (1948)
  • CullenJF

    Occult temporal arteritis

    British Journal of Ophthalmology

    (1967)
  • CullenJ

    Temporal arteritis

    British Journal of Ophthalmology

    (1972)
  • CullenJF et al.

    Ophthalmic complications of giant cell arteritis

    Survey of Ophthalmology

    (1976)
  • DaguptaB et al.

    Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymalgia rheumatica and giant cell arteritis

    Annals of the Rheumatic Diseases

    (1989)
  • DelecoeuillerieG et al.

    Polymyalgia rheumatica and giant cell arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients)

    Annals of the Rheumatic Diseases

    (1988)
  • DentRG et al.

    Autoimmune thyroid disease and the polymyalgia rheumatica-giant cell arteritis syndrome

    Clinical Endocrinology

    (1978)
  • EllisME et al.

    The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome

    Annals of the Rheumatic Diseases

    (1983)
  • FaarvangKL et al.

    Giant cell arteritis

    Journal of Internal Medicine

    (1989)

    • Cited by (8)

    • Current concepts in giant cell (temporal) arteritis

      1997, Survey of Ophthalmology

    • Complications and prognosis of polymyalgia rheumatica

      2014, Aktuelle Rheumatologie

    • Management of giant cell arteritis: Our 27-year clinical study: New light on old controversies

      2003, Ophthalmologica

    • Does this patient have temporal arteritis?

      2002, JAMA

    • Steroid management in giant cell arteritis

      2001, British Journal of Ophthalmology

    • Giant cell arteritis. Epidemiology, etiology and pathogenesis

      2000, APMIS
    View all citing articles on Scopus
    View full text
    Copyright © 1991 Published by Elsevier Ltd.